2024-04-04 Purchase(A) | 2024-04-17 4:14 pm | Surrozen Inc. | SRZN | COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner | 193,548 | $15.5 | $2,999,994 | 326,992 (Indirect) | View |
2024-04-04 Purchase | 2024-04-08 4:23 pm | Surrozen Inc. | SRZN | COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner | 193,548 | $15.5 | $2,999,994 | 2,236,955 (Indirect) | View |
2024-02-12 Purchase | 2024-02-14 4:15 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 2,222,222 | $4.5 | $9,999,999 | 22,999,565 (Indirect) | View |
2023-03-10 Purchase | 2023-03-14 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) | View |
2023-02-08 Purchase | 2023-02-10 4:32 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) | View |
2023-01-19 Purchase | 2023-01-23 4:25 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) | View |
2023-01-17 Purchase | 2023-01-19 4:18 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) | View |
2022-11-21 Purchase | 2022-11-23 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) | View |
2021-02-17 Sale | 2021-02-19 5:31 pm | CONSTELLATION PHARMACEUTICALS INC | CNST | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP COLUMN GROUP GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim 10% Owner | 10,000 | $36.95 | $369,503 | 6,230,638 (Indirect Direct) | View |
2020-11-16 Sale | 2020-11-18 7:06 pm | Revolution Medicines Inc. | RVMD | COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP PONOI CAPITAL LP Ponoi Capital II LP Ponoi Management LLC Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V 10% Owner | 2,027,156 | $36.4 | $73,788,478 | 5,950,228 (Indirect Direct) | View |
2020-09-01 Purchase | 2020-09-03 5:32 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Svennilson Peter GOEDDEL DAVID V Director 10% Owner | 64,089 | $17.65 | $1,131,358 | 18,242,932 (Indirect Direct) | View |
2020-08-27 Purchase | 2020-08-31 5:02 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 62,494 | $17.83 | $1,114,382 | 18,178,843 (Indirect Direct) | View |
2020-08-21 Purchase | 2020-08-25 6:50 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 18,445 | $17.96 | $331,349 | 18,116,349 (Indirect Direct) | View |
2020-08-13 Purchase | 2020-08-17 7:12 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 64,313 | $17.65 | $1,135,362 | 18,097,904 (Indirect Direct) | View |
2020-07-30 Purchase | 2020-08-03 5:57 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 732 | $17.99 | $13,169 | 18,033,591 (Indirect Direct) | View |
2020-07-28 Purchase | 2020-07-30 8:08 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 4,105 | $17.99 | $73,849 | 18,032,859 (Indirect Direct) | View |
2020-07-24 Purchase | 2020-07-28 5:40 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner | 72,583 | $17.93 | $1,301,643 | 18,028,754 (Indirect Direct) | View |
2020-07-22 Purchase | 2020-07-23 5:39 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group II GP LP Column Group Management LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Ponoi Management LLC PONOI CAPITAL LP Director 10% Owner | 193 | $18 | $3,474 | 17,976,977 (Indirect Direct) | View |
2020-04-08 Purchase | 2020-04-09 5:53 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 112,602 | $14.95 | $1,683,400 | 17,721,978 (Direct) | View |
2020-04-03 Purchase | 2020-04-07 7:23 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 138,315 | $14.17 | $1,960,233 | 17,609,376 (Direct) | View |
2020-03-31 Purchase | 2020-04-02 6:08 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 250,984 | $12.4 | $3,111,021 | 17,471,061 (Direct) | View |
2020-03-23 Purchase | 2020-03-25 7:42 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 301,180 | $11.89 | $3,580,544 | 17,220,077 (Direct) | View |
2020-03-19 Purchase | 2020-03-23 6:59 pm | CONSTELLATION PHARMACEUTICALS INC | CNST | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 41,674 | $22.48 | $936,929 | 6,210,531 (Indirect Direct) | View |
2020-03-19 Purchase | 2020-03-23 5:06 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 291,546 | $11.68 | $3,404,773 | 16,918,897 (Direct) | View |
2020-03-05 Purchase | 2020-03-06 6:01 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 8,307 | $18 | $149,526 | 16,627,351 (Direct) | View |
2020-03-02 Purchase | 2020-03-04 7:29 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 62,868 | $17.97 | $1,129,425 | 16,619,044 (Direct) | View |
2020-02-26 Purchase | 2020-02-28 7:12 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 75,447 | $17.91 | $1,351,593 | 16,556,176 (Direct) | View |
2020-02-06 Purchase | 2020-02-10 4:51 pm | NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP 10% Owner | 44,900 | $15.96 | $716,604 | 16,480,729 (Direct) | View |